Racial/ethnic disparities in risk of breast cancer mortality by molecular subtype and stage at diagnosis.
By: Nicole C Lorona, Kathleen E Malone, Christopher I Li

University of Washington, Seattle, WA, USA. nlorona@fredhutch.org.
2020-02-19; doi: 10.1007/s10549-021-06311-7
Abstract

Purpose

Previous research has found significant survival disparities between Black and White women among select stages and subtypes of breast cancer, however other racial/ethnic groups have been less well-studied. This study expands on previous research, examining differences in breast cancer-specific mortality across multiple racial and ethnic groups.

Methods

Women diagnosed with a first primary invasive breast cancer between 2010 and 2016 who were 20-85 years of age at diagnosis were identified from 18 Surveillance, Epidemiology, and End Results (SEER) registries. Subtypes were defined by joint hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status. Cox proportional hazards models for each stage and subtype were fit, with non-Hispanic white women as the reference group. Effect modification by age at diagnosis (< 50, ≥ 50) was found and thus analyses were age-stratified.

Results

After multivariable adjustment, younger Black women had greater risks of breast cancer-specific death for all stages of HR+/HER2-, and certain stages of HR+/HER2+ , TN, and HR-/HER2 + breast cancer. Asian/Pacific Islander women generally had a lower hazard of breast cancer-specific death. Older Hispanic White women had a lower hazard of breast cancer-specific death for stages I-III HR + /HER2- and stage II TN breast cancer.

Conclusions

These findings demonstrate that different racial/ethnic groups experience different risks of breast cancer-specific mortality by stage and subtype. Efforts to address survival disparities should place additional focus on young Black women, as they experience meaningful disparities in breast cancer-specific mortality.



© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

PMID:34651254






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements